Thesis (M.Sc.(Chemistry)) -- University of Limpopo, 2018. / Refer to the document / NRF-Sasol Inzalo Foundation

A number of toxicities associated with methylene chloride have been found in both human subjects and mice. However, relatively few studies have probed immunotoxicities of methylene chloride. In order to examine possible immunotoxicities or immunomodulating effects of methylene chloride, several tests of cellular immune function were performed using both human in In Vitro studies and a mouse model. Body weights and specific organ weights of thymus, spleen, liver, and kidney were normal in CD-1 mice given various concentrations of methylenechloride. However, a significantly reduced mitogenic response to phytohemagglutinin (PHA} and reduced interleukin-2 (IL-2} production was found in these methylene-chloride-treated mice. The findings in the mouse model provide additional evidence that immune suppression may be associated with exposure to methylene chloride. Splenic mononuclear cells isolated from CD-1 mice were incubated with various concentrations of methylene chloride in vitro and investigated for blastogenic response to mitogen PHA and IL-2 production. The results show no significant difference between methylene-chloride-treated cells and the cells treated with growth media. Peripheral blood mononuclear cells isolated from healthy donors were incubated with various concentrations of methylene chloride and tested for blastogenic activity, natural killer (NK) cell activity, and IL-2 production. The findings showed that the NK cell activity, the T-cell blastogenesis in response to PHA mitogen, and IL-2 production activity were not affected.

Sputum induction by inhalation of hypertonic saline has been used for more than15 years. It has become one of the most intriguing methods to study airway inflammation. It is the only direct, non-invasive method for measuring airway inflammation indices.Sputum induction has been used in the diagnosis of many respiratory illnesses including asthma, chronic pulmonary obstructive disease, tuberculosis, chronic cough, lung cancer and Pneumocystis Carinii on patients who are unable to produce sputum spontaneously. There are currently many different methods used worldwide to induce sputum, but there is a lack of one generally accepted gold standard method. The proposed protocols for sputum induction proved to be safe, simple and produced satisfactory amount of expectorate. However, it did not contain enough cells from the lower respiratory tract and was contaminated by squamous cells when compared to another method based on the work of F. E. Hargreave. Investigation demonstrated that the use of impulse oscillometry, which requires no effort from patients, needs further research with larger study samples before it could be used instead of spirometry to evaluate airway obstruction. Initial methylene blue stain of the fresh expectorate smear was shown to be useful tool for identifying grossly contaminated sputum samples by squamous epithelial cells.Our first study group included 20 volunteers in good health. Sputum was induced by inhalation of 3% saline mist created by ultrasonic nebulizer at maximum output (4ml/min). Sputum induction intervals lasted 4-5 minutes with cumulative duration of induction about 4-15 minutes which was tolerated well. Lung function was evaluated for obstruction at baseline and every 5 minutes with spirometry and impulse oscillometry.The whole expectorated sample was processed and slides were stained with HEMA 3stain. With this method we were able to collect a mean of 6.1 ml expectorate. The mean total cell count was 804 000 with high proportion of squamous cells. The second study group included 5 volunteers in good health. This method utilized 3%, 4% and 5% saline mist for inhalation, 7 minutes each. Ultrasonic nebulizer was set at low output of 0.9 ml/min. This procedure was also tolerated well without major adverse effects. Lung function was evaluated at baseline and every 7 minutes for obstruction. Only dense portions of expectorate were selected and processed. Slides were stained with Wright stain. This method produced much more total cells with a mean of 3 385 000 per gram of sputum which came from the lower airways and were not contaminated by squamous cells. The second method was far superior producing adequate sputum sample with cells from the lower airways and minimal squamous cell contamination and will be used in our Breath Lab.

Malaria is a challenging infection with increasing and wide-spread treatment failure risk due to resistance. With a estimated death toll of 1-3 Million per year, most cases of Malaria affect children under the age of five years in Sub-Saharan Africa. In this thesis, I analyse the current status of malaria control (focussing on diagnosis and therapy) in Burkina Faso to show how this disease burdens public health in endemic countries and to identify possible approaches to improvement. MB is discussed as a therapeutic option under these circumstances. Burkina Faso is used as a representative example for a country in Sub-Saharan Africa with high endemicity for malaria and is here portrayed, its health system characterised and discussed under socioeconomic aspects. More than half of this country’s population live in absolute poverty. The burden that malaria, especially treatment cost, poses on these people cannot be under-estimated. A retrospective study of case files from the university pediatric hospital in Burkina Faso’s capital, Ouagadougou, shows that the case load is huge, and especially the specific diagnosis of severe malaria is difficult to apply in the hospital’s daily routine. Treatment policy as proposed by WHO is not satisfactorily implemented neither in home treatment nor in health services, as data for pretreatment clearly show. In the face of growing resistance in malaria parasites, pharmacological combination therapies are important. Artemisinins currently are the last resort of malaria therapy. As I show with homology models, even this golden bullet is not beyond resistance development. Inconsidered mass use has rendered other drugs virtually useless before. Artemisinins should thus be protected similar to reserve antibiotics against multi-resistant bacteria. There is accumulating evidence that MB is an effective drug against malaria. Here the biological effects of both MB alone and in combination therapy is explored via modeling and experimental data. Several different lines of MB attack on Plasmodium redox defense were identified by analysis of the network effects. Next, CQ resistance based on Pfmdr1 and PfCRT transporters as well as SP resistance were modeled in silico. Further modeling shows that MB has a favorable synergism on antimalarial network effects with these commonly used antimalarial drugs, given their correct application. Also from the economic point of view MB shows great potential: in terms of production price, it can be compared to CQ, which could help to diminuish the costs of malaria treatment to affordable ranges for those most affected and struk by poverty. Malaria control is feasible, but suboptimal diagnosis and treatment are often hindering the achievment of this goal. In order to achieve malaria control, more effort has to be made to implement better adjusted and available primary treatment strategies for uncomplicated malaria that are highly standardised. Unfortunately, campaigns against malaria are chronically underfinanced. In order to maximize the effect of available funds, a cheap treatment option is most important, especially as pharmaceuticals represent the biggest single matter of expense in the fight against malaria. / Malaria ist eine Krankheit, die uns vor große Herausforderungen stellt. Insbesondere die weltweit verbreiteten Resistenzen, die viele Therapieoptionen nutzlos werden lassen, haben den Kampf gegen die Malaria in den letzten Jahrzehnten deutlich verkompliziert. Schätzungen gehen davon aus, dass Malaria jährlich 1 bis 3 Millionen Todesopfer fordert. Mortalität und Morbidität der Erkrankung konzentrieren sich dabei in besonderer Weise auf Kinder unter fünf Jahren in Afrika südlich der Sahara. In der hier vorgestellten Doktorarbeit analysiere ich den aktuellen Stand der Malaria-Kontrolle in Burkina Faso und zeige beispielhaft auf, warum diese Krankheit eine derart große Bürde für die Volksgesundheit darstellt und wo Ansatzpunkte zur Verbesserung der Kontrollmaßnahmen zu sehen sind, mit einem besonderen Fokus auf Diagnostik und Therapieoptionen. Dabei wird MB als Therapieoption genauer beleuchtet. Um die besonderen Gegebenheiten eines Landes wie Burkina Faso - welches hier als repräsentatives Beispiel für einen Staat mit hoher Endemizität für Malaria herangezogen wird - aufzuzeigen, wird ein Porträt des Landes und seines Gesundheitssystems insbesondere unter Sozio- Ökonomischen Gesichtspunkten gezeichnet. Burkina Faso ist ein sehr armes Land, über die Hälfte seiner Bevölkerung lebt unterhalb der Armutsgrenze. Die Kosten von Malaria sind für diese Menschen gigantisch, und insbesondere die Kosten von Medikamenten wiegen schwer. Eine retrospektive Studie aus Fallakten des Universitäts-Kinderkrankenhauses in Burkina Fasos Hauptstadt Ouagadougou zeigt vor allem, dass allein die Fallzahlen überwältigend sind, und vor allem die spezifische Diagnose der schweren Verlaufsform der Malaria ist unter den vorherrschenden Bedingungen eine Mammutaufgabe. Die Behandlungsvorschriften wie von der WHO vorgegeben werden weder vom Gesundheitssystem noch von der Therapie zu Hause erfüllt, wie in den präsentierten Daten für die Vorbehandlung zeigen. Die zur Verfügung stehenden Malaria-wirksamen Therapeutika sind leider dank Resistenzentwicklung - oft durch unbedachten Masseneinsatz verursacht - sehr begrenzt. Artemisinine sind momentan das einzige Mittel gegen welches noch keine Resistenzen im Feld nachgewiesen wurden. Mittels Homologie-Modellierung zeige ich auf wie einfach eine solche Resistenzentwicklung jedoch denkbar wäre. Artemisinine sollten daher durch sehr gezielten Einsatz als ”letzter Trumpf” möglichst lange vor Resistenzentwicklung geschützt werden, ähnlich wie Reserveantibiotika gegen Multi-resistente Keime. MB ist ein hervorragender Kandidat für eine Kombinationsbehandlung gegen Malaria und eventuell eine Option, Artemisinine länger zu ”schonen”. Hier wird dieses Medikament mit bioinformatischen Mitteln genauer in seinen Wirkmechanismen beleuchtet und in Kombination mit anderen Medikamenten getestet mittels einer experimentell gestützten bioinformatischen Pathway-Modellierung. Durch diese Netzwerk-Analyse wurden verschiedene Angriffspunkte von MB auf das Redox-Netzwerk der Malariaerreger identifiziert. Daraufhin wurden CQ und SP-Resistenzen in silico simuliert. Weitere Analysen zeigten dabei, dass MB synergisitische Wirkungen mit anderen Therapeutika gegen Malaria aufzeigt, wenn sie zielgerichtet eingesetzt werden. Finanziell gesehen hat MB Potenzial, ein zweites CQ zu werden, und somit endlich wieder die Kosten der Behandlung für Menschen die in Armut leben erschwinglich zu machen. Malaria Kontrolle ist erreichbar, aber suboptimale Diagnosestellung und Behandlung behindern das Erreichen dieses Zieles. Hierfür muss eine angepasste, dezentrale und hochgradig standardisierte Primärbehandlung unkomplizierter Malaria implementiert werden und für eine bessere Verfügbarkeit dieser gesorgt werden. Leider leidet die Finanzierung der Kampagnen gegen Malaria an chronischer Unterversorgung. Um den maximalen Nutzen aus den vorhandenen Mitteln ziehen zu können ist eine günstigere medikamentöse Therapie ein entscheidender Beitrag, zumal Medikamente den größten Einzelbetrag im Kampf gegen Malaria verbrauchen.

Nanostructured molybdenum trioxide (MoO3) was synthesized and used as a precursor in a comparative study, along with commercial MoO3, to synthesize molybdenum dioxide (MoO2) nanoparticles. Scanning electron microscope (SEM) images revealed the particles to be approximately 30-50 nm in diameter. X-ray diffraction (XRD) confirmed MoO3 was fully reduced to MoO2 in all cases. Time dependent experiments showed that within two hours no traces of MoO3 are present. All of the experiments showed the materials were excellent absorbent materials, as well as photocatalysts. Both MoO2 materials performed almost exactly the same, with both samples being able to remove 100% of the methylene blue (MB) in one minute with light, and in two minutes without light. The morphology of MoO2 was controlled in a comparative study by varying the concentration of cetyltrimethylammonium bromide (CTAB) present during the hydrothermal reaction. As the concentration of CTAB increased, the morphology of the material changed from nanoparticles, to nanospheres, to microspheres, to hollow microspheres, and finally a highly agglomerated version of microspheres and particles combined, as confirmed by SEM images. A formation mechanism for the formation of the various sized spheres was proposed with a combination of aggregation and Ostwald ripening. XRD confirmed that all of the MoO3 was reduced to MoO2, along with no residual peaks from the CTAB that was present during the reaction. Upon trying to mix some of the materials into the MB solutions, it became obvious that some of the materials were hydrophobic. The decontamination results once again showed that the synthesized MoO2 materials were not only photocatalysts, but adsorbents as well. Samples synthesized with 0.1-5 mM CTAB were able to remove 100% of the MB in 10 minutes or less. Samples synthesized with 10 mM CTAB were able to remove 54.4% and 35% of the MB in 10 minutes, with and without light, respectively. Samples synthesized with 15 mM CTAB were able to remove 29.4% and 26.3% of the MB in 10 minutes, with and without light, respectively. The apparent decrease in decontamination performance was proposed to be caused by surface morphology induced hydrophobicity. A mechanism to describe why the hydrophobic particles were still able to decontaminate the water was proposed to be caused by coming into direct contact with the magnetic stirrer as the water level dropped due to sample collection. MoO2 nanoparticles were successfully synthesized onto a copper substrate, in a single step, via a hydrothermal synthesis technique. It is believed to be the first report of such a synthesis method. XRD confirmed all of the MoO3 had been reduced to MoO2, and also confirmed that no other compounds had formed between the molybdenum and copper. SEM images of the MoO2 coated copper substrate showed uniform nanoparticles ranging from 30-50 nm. The MoO2 coated copper substrate was able to decontaminate 57.5% of the MB from water in 10 minutes without exposure to light, while it was able to decontaminate 71.7% of the MB from water in 10 minutes with exposure to light.

Thesis (Ph. D.)--University of Chicago, Department of Chemistry, 2002. / Includes bibliographical references. Also available on the Internet.

Thesis (Ph. D.)--University of Chicago, Department of Chemistry, August 2003. / Includes bibliographical references. Also available on the Internet.

Thesis--Ph. D., University of Hong Kong, 1983.

The elderly are at increased risk for developing psychiatric diseases, which include Alzheimer's disease, depression, anxiety and suicide. The probability of multiple disease comorbidity is also increased in the elderly. At the cellular level, the loss of protein homeostasis is often at the root of disease emergence, and thus the scientific community is searching for ways to help maintain this balance. A vast group of proteins that are paramount to balancing and counterbalancing protein levels is the molecular chaperone protein group, which has evolved a tremendous variety of functions in the cell. They aid in protein trafficking, folding, receptor signaling, neurotransmission, vesicle forming and fusion, protein degradation, and apoptosis, among other activities. Despite their best efforts, disease still ensues, but because of their vast number and multiple abilities, it may be possible to modulate these proteins as a way to treat and prevent disease. Chaperones are of particular interest in diseases of aging, because chaperone induction and effectiveness is reduced with age. In addition, many diseases of the elderly are brought on by aberrant protein accumulation, like Alzheimer's disease. As a result, the hypothesis of this dissertation is whether the modulation of molecular chaperones changes disease pathology. A molecular chaperone family that is important to protein degradation is the Hsp70 chaperone complex. Hsp70 proteins have specialized function depending on cell type and cellular compartment, but Hsp70 proteins are very important for protein synthesis and degradation. As a result, they are in a position to contribute to the regulation of proteins that become aberrant. In recent years scientific literature has indicated that compounds that inhibit the enzymatic ATP hydrolysis of these proteins promote tau degradation, which accumulates in Alzheimer's disease. Alzheimer's disease is the sixth leading cause of death in the U.S., it is a progressive neurodegenerative disease, and is caused by the aberrant accumulation of the amyloid beta and tau proteins. Here, we show that treatment with the Hsp70 inhibitor methylene blue, reduces tau, saves neurons, and restores cognition, in a mouse model of tau accumulation (rTg4510). Cognitive rescue occurred despite a severe tangle load, equal to control treated tau transgenic mice. This study shows that reducing soluble tau can restore cognition, reducing tangles is not necessarily to ameliorate cognition, and saving neurons is not sufficient to increase cognition if they are burdened with soluble tau. This work shows that methylene blue does not affect the the number of tau tangles in this model, as suggested by in vitro data. It also suggests that further work into the development of Hsp70 ATPase inhibitors may find success in alleviating the soluble tau burden found in Alzheimer's disease. The co-chaperone FKBP5 is also of extreme importance, not because it is essential, but because research has implicated this protein with a host of psychiatric diseases. Single nucleotide polymorphisms in this gene, which increase the levels of FKBP5, interact with averse traumatic events to enhance the likelihood of developing mood and anxiety disorders, including major depressive disorder, post-traumatic stress disorder, bipolar disorder, and suicide. Moreover, we have found that FKBP5 protein levels increase with age in the human brain, increasing the risk for the elderly of developing disease if exposed to traumatic stress. Here, we tested the hypothesis that FKBP5 negatively regulates resilient behavior. We found that FKBP5 levels increase with age in the wild type mouse brain, and that wild type mice display reduced resiliency with age. FKBP5-/- mice, on the other hand, show enhanced resiliency to stress at all ages tested, and are protected from aging-induced despair. At the molecular level, FKBP5 is a robust inhibitor of the glucocorticoid receptor, which is responsible for the shut-off of the hypothalamic-pituitary-adrenal axis. In addition, excess glucocorticoid levels in the blood is a robust marker of psychiatric disease. Consequently, FKBP5 may be causing disease through enhanced levels of glucocorticoids. FKBP5-/- mice display reduced corticosterone after stress. Moreover, corticosterone production increases with age, and FKBP5-/- mice are protected from this increase. These studies are the first to show that reducing the levels of FKBP5 is a promising therapeutic option for the treatment of mood disorders in the elderly, resiliency naturally declines with age due to FKBP5, corticosterone levels after stress rise due to FKBP5, and that the ablation of this gene increases resiliency and prevents aging- induced despair. As a whole, these data show that the modulation of chaperone proteins has the potential for developing new therapies for the treatment of psychiatric diseases of the elderly.

abstract / Chemistry / Doctoral / Doctor of Philosophy